Answers are grounded in this paper and cite their sources.
Monotherapy with TACE, or Lenvatinib, or PD-1 inhibitors has shown limited efficacy over standard first-line chemotherapy in advanced and metastatic ICC. This work suggested the combined potency of these treatments and well-tolerance.
No takes yet. Share an insight, caveat, or question.
Ning et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: